The fact that we found positive effects already with moderate-intensity AEX may indicate that this was sufficient to induce a considerable release of BDNF in PD patients, which would be supported by other studies documenting BDNF-response in neurological conditions (Gold et al., 2003). This evidence concerns the gene BDNF and Parkinson disease.